Back

Identification of predictors of response to initial oral combination therapy in WHO-functional class II or III PAH patients: A post-hoc analysis of the AMBITION study

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters Pulmonary Hypertension ESC Premium Access ESC Congress 2020

About the speaker

Photo
Associate Professor Masaru Hatano

The University of Tokyo Hospital, Tokyo (Japan)

62 More presentations in this session

Presentation thumbnail
Shift in transcriptional landscape of human right ventricle in chronic thromboembolic pulmonary arterial hypertension
Ms L. Jafari (Giessen, DE)
Abstract Slides
Presentation thumbnail
Relationship between right ventricular diastolic dysfunction, right atrial phasic function and ventricular filling in pulmonary arterial hypertension
Mr J. Wessels (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Aetiology of sarcoidosis-associated pulmonary hypertension
Mr H. Mathijssen (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Pre-operative pulmonary artery pulsatility index does not predict mortality post cardiac transplantation but PVR is a prognostic tool in LVAD-bridged patients.
Doctor N. Bart (Boston, US)
Abstract Slides
Presentation thumbnail
Venous lactate predicts adverse outcomes in normotensive pulmonary embolism
Doctor M. Ebner (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: Insights from the randomised controlled TRITON study
29 August 2020
thumbnail
Congress Presentation
Predictors of spot urinary sodium in patients with acute decompensated heart failure: a sub analysis of the TAILOR-AHF randomized trial
20 May 2023
thumbnail
Congress Presentation
Predictors of change in peak oxygen consumption following exercise training in heart failure with preserved ejection fraction
29 June 2021
thumbnail
Congress Presentation
Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources